disposition

(redirected from drug disposition)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.

Disposition

Act of disposing; transferring to the care or possession of another. The parting with, alienation of, or giving up of property. The final settlement of a matter and, with reference to decisions announced by a court, a judge's ruling is commonly referred to as disposition, regardless of level of resolution. In Criminal Procedure, the sentencing or other final settlement of a criminal case. With respect to a mental state, means an attitude, prevailing tendency, or inclination.

disposition

n. the court's final determination of a lawsuit or criminal charge.

disposition

in Scottish conveyancing practice the name for the deed that transfers ownership of (conveys) real or heritable property. Once it was necessary to use the word dispone, but this has not been the case for some time. To obtain a REAL RIGHT good against the world the title must be recorded in the REGISTER OF SASINES or the LAND REGISTRY.

DISPOSITION, French law. This word has several acceptations; sometimes it signifies the effective marks of the will of some person; and at others the instrument containing those marks.
     2. The dispositions of man make the dispositions of the law to cease; for example, when a man bequeaths his estate, the disposition he makes of it, renders the legal disposition of it, if he had died intestate, to cease.

References in periodicals archive ?
This study also emphasizes the wide spectrum of food and beverage products which may affect drug disposition and further studies are required to examine other plant products.
In particular, differences specific to ethnicity can substantially contribute to interindividual variability of drug disposition. Often cited is the 2005 exclusive FDA approval for African-Americans of an antihypertensive medication with isosorbide dinitrate and hydralazine hydrochloride (13).
Among their topics are coordinating uptake and efflux transporters in drug disposition, predicting the intestinal solubility of poorly soluble drugs, and using computer reasoning about qualitative and quantitative information to predict metabolism and toxicity.
Titled 'Humanized Animal Models - Potential Tools for the Study of Drug Transporters', Laurent Salphati, Senior Scientist, Drug Metabolism and Pharmacokinetics from Genentech will be discussing: Uses and limitations of in vitro transporter assays in the predictions of drug disposition and DDIs as well as humanised models available and characterisations.
Lundeen is responsible for the administrative and scientific activities of the Toxicology, Drug Disposition & Pharmacokinetics component in the conduct and support of preclinical safety studies and clinical studies across the continuum of drug discovery, development, and commercialization.
Significant interindividual variability exists in drug disposition and response (5).
Steve Hood, Director, Biotransformation & Drug Disposition, GSK
Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999;37:485-505.

Full browser ?